Washington Statutes
§ 18.64.257 — Prescription of dialysis devices and legend drugs by dialysis programs.
Washington § 18.64.257
This text of Washington § 18.64.257 (Prescription of dialysis devices and legend drugs by dialysis programs.) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Wash. Rev. Code § 18.64.257 (2026).
Text
(1)This chapter shall not prevent a medicare-approved dialysis center, a facility operating a medicare-approved home dialysis program, a manufacturer, or a wholesaler, from selling, delivering, possessing, or dispensing directly to its dialysis patients, if prescribed by a practitioner acting within the scope of the practitioner's practice, those dialysis devices and legend drugs, including commercially available dialysate, used by home dialysis patients, in case or full shelf lots, as determined by the commission.
(2)The commission shall adopt rules to implement this section.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
[2022 c 23 s 1;2013 c 19 s 20;1987 c 41 s 1.]
Nearby Sections
15
§ 18.04.015
Purpose.§ 18.04.025
Definitions.§ 18.04.045
Board—Officers and staff—Powers and duties.§ 18.04.055
Board—Rules.§ 18.04.065
Board—Fees—Disposition.§ 18.04.080
Compensation and travel expenses of members.§ 18.04.180
Reciprocity.§ 18.04.183
Accountants from foreign countries.§ 18.04.295
Actions against CPA license.Cite This Page — Counsel Stack
Bluebook (online)
Washington § 18.64.257, Counsel Stack Legal Research, https://law.counselstack.com/statute/wa/18.64.257.